عدل animation حجم الشاشة
Resize out
Resize in
Resize إعادة الضبط
Done تم
CureVac - Ingmar Hoerr, CEO

CureVac - Ingmar Hoerr, CEO

مرة 1,215 شوهد

التحقق البشري

8.1
شكرًا لك, تم تسجيل تصويتك وسيظهر قريبًا.
نعم
لا
وصف الفيديو:

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

التعليقات